Enteral nutrition formula selection: current evidence and implications for practice

Area of Science:

• Nutrition Science
• Medical Foods Regulation

Background:

• Numerous enteral nutrition (EN) formulas have emerged, aiming for improved patient outcomes.
• Research supporting these formulas is often conflicting and unclear.
• Enteral nutrition products are classified as medical foods by the FDA, exempting them from stringent premarket review.

Purpose of the Study:

• To highlight the evolving landscape of EN formulas.
• To emphasize the regulatory status of EN products as medical foods.
• To underscore the need for critical evaluation of specialty EN formulas in clinical practice.

Main Methods:

• Review of existing literature on enteral nutrition formulas.
• Analysis of the regulatory framework for medical foods in the U.S.
• Examination of the characteristics and purported benefits of specialty EN formulas.

Main Results:

• Specialty EN formulas are designed with pharmacologic properties, including immune-enhancing ingredients like arginine, glutamine, nucleotides, and omega-3 fatty acids.
• The efficacy and clinical utility of many specialty formulas are not well-established due to inconsistent research findings.
• The regulatory oversight for medical foods differs significantly from pharmaceuticals.

Conclusions:

• Clinicians must carefully assess the quality of evidence, patient suitability, clinical outcomes, and cost-effectiveness before using specialty EN formulas.
• Evidence-based practice necessitates a critical approach to the selection and application of specialized nutritional products.
• Further high-quality research is needed to clarify the role of specialty EN formulas in patient care.